chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Constipation
Clinical narrative: constipation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 60 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for Covid-19 immunisation. The following information was reported: CONSTIPATION (non-serious), outcome "unknown", described as "constipation". Therapeutic measures were taken as a result of constipation.  Additional information: Caller wanted to know if other people have experienced the side effect of constipation with second shot of the vaccine. She said she (50 years old female) her boyfriend (52 years old male) and sister (60 years old) are experiencing bad constipation after the Pfizer covid vaccine. Her doctor has prescribed laxatives and they are taking 8-9 prunes a day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021510552 Same Vaccine/event, different  patient;US-PFIZER INC-2021498931 Same Vaccine/event, different  patient
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Lymphadenopathy
Clinical narrative: minor dull headache; tired; Felt like I had a swollen lymph node on my left side under my arm; experienced some pain - like a sore muscle - in my upper back/right shoulder area; experienced some pain - like a sore muscle - in my upper back/right shoulder area; extreme chills/ teeth chattering and shivering; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 29Apr2021 (Lot number: EW0176) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, lot number=ER8737, administration time=09:15 AM, dose number=1), administration date: 29Apr2021, when the patient was 40 years old, for covid-19 Immunisation, reaction(s): "sore arm". The following information was reported: HEADACHE (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "minor dull headache"; FATIGUE (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "tired"; LYMPHADENOPATHY (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "Felt like I had a swollen lymph node on my left side under my arm"; ARTHRALGIA (non-serious), MYALGIA (non-serious) all with onset 29Apr2021, outcome "recovered" (2021) and all described as "experienced some pain - like a sore muscle - in my upper back/right shoulder area"; CHILLS (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "extreme chills/ teeth chattering and shivering". Therapeutic measures were not taken as a result of headache, fatigue, lymphadenopathy, arthralgia, myalgia, chills.  Additional information: After the 2nd dose - patient had a minor dull headache the day she received the vaccine and generally felt tired. Felt like she had a swollen lymph node on her left side under her arm. The 2nd night after she received it, she experienced some pain - like a sore muscle - in her upper back/right shoulder area, extreme chills, teeth chattering and shivering, for about 3 hours overnight. When she woke up after the 2nd night - all symptoms seem to have disappeared and felt fine. Covid was not reported prior vaccination. Patient was not tested for Covid post vaccination. Known allergies and other medical history were reported as None  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: minor dull headache; tired; Felt like I had a swollen lymph node on my left side under my arm; experienced some pain - like a sore muscle - in my upper back/right shoulder area; experienced some pain - like a sore muscle - in my upper back/right shoulder area; extreme chills/ teeth chattering and shivering; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 29Apr2021 (Lot number: EW0176) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, lot number=ER8737, administration time=09:15 AM, dose number=1), administration date: 29Apr2021, when the patient was 40 years old, for covid-19 Immunisation, reaction(s): "sore arm". The following information was reported: HEADACHE (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "minor dull headache"; FATIGUE (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "tired"; LYMPHADENOPATHY (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "Felt like I had a swollen lymph node on my left side under my arm"; ARTHRALGIA (non-serious), MYALGIA (non-serious) all with onset 29Apr2021, outcome "recovered" (2021) and all described as "experienced some pain - like a sore muscle - in my upper back/right shoulder area"; CHILLS (non-serious) with onset 29Apr2021, outcome "recovered" (2021), described as "extreme chills/ teeth chattering and shivering". Therapeutic measures were not taken as a result of headache, fatigue, lymphadenopathy, arthralgia, myalgia, chills.  Additional information: After the 2nd dose - patient had a minor dull headache the day she received the vaccine and generally felt tired. Felt like she had a swollen lymph node on her left side under her arm. The 2nd night after she received it, she experienced some pain - like a sore muscle - in her upper back/right shoulder area, extreme chills, teeth chattering and shivering, for about 3 hours overnight. When she woke up after the 2nd night - all symptoms seem to have disappeared and felt fine. Covid was not reported prior vaccination. Patient was not tested for Covid post vaccination. Known allergies and other medical history were reported as None  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Felt nauseated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Apr2021 10:30 (Lot number: EW0150) at the age of 50 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 13Apr2021, outcome "recovered" (14Apr2021), described as "Felt nauseated".  Additional information: At the end of the report, Caller stated that she felt nauseated after her first Covid vaccine. when she woke up in the morning. The patient did not receive any vaccine within 4 weeks prior to Covid vaccine. Not visited Emergency Room and Physician Office.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Pain in extremity
Clinical narrative: Soreness in her left armpit; Hurts to raise her left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 10:50 (Lot number: EN6198) at the age of 42 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Lot no.: EL9261, Left Arm.), administration date: 09Apr2021, for Covid-19 Immunisation. The following information was reported: AXILLARY PAIN (non-serious) with onset 01May2021, outcome "not recovered", described as "Soreness in her left armpit"; PAIN IN EXTREMITY (non-serious) with onset 01May2021, outcome "not recovered", described as "Hurts to raise her left arm".  Additional information: The patient received her second dose on Friday, 30Apr2021. She has soreness in her left armpit, it hurts to raise her left arm. She received her second dose in her left arm. The soreness in her armpit started the day after she received her second Covid 19 vaccine, on 01May2021. She woke up that Saturday and her armpit was sore. The soreness is staying about the same. She hasn't seen her primary care doctor in 3 to 4 years. Reporter seriousness for soreness in her left armpit, hurts to raise her left arm was Unspecified. Vaccine was not administered at Facility. AE(s) did not required to visit Emergency Room/Physician Office. The patient had not received any vaccine within 4 weeks prior Vaccinations. The patient had no AE(s) prior vaccinations.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: I was not feeling good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: MALAISE (non-serious), outcome "unknown", described as "I was not feeling good".  Additional information: The caller stated that I was having an appointment on 29th as I was not feeling good, and I want to reschedule coming up for my vaccine. I have had the first one.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Neuralgia, Pain
Clinical narrative: I began having nerve and muscle pain on the left side of my body; I began having nerve and muscle pain on the left side of my body; 3 hours after my body became sore and remained sore for about two days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2, solution for injection), administered in arm left, administration date 20Apr2021 (Lot number: ER8731) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Syncope" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Mitral Valve" (unspecified if ongoing); "Shellfish allergy" (unspecified if ongoing); "Pet dander allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cipro; Bactrium; Percocet. The following information was reported: PAIN (non-serious) with onset 20Apr2021, outcome "recovered" (22Apr2021), described as "3 hours after my body became sore and remained sore for about two days"; NEURALGIA (non-serious), MYALGIA (non-serious) all with onset 23Apr2021, outcome "not recovered" and all described as "I began having nerve and muscle pain on the left side of my body". The events "3 hours after my body became sore and remained sore for about two days", "i began having nerve and muscle pain on the left side of my body" and "i began having nerve and muscle pain on the left side of my body" were evaluated at the physician office visit. Therapeutic measures were taken as a result of neuralgia, myalgia.  Additional information: The patient received the Pfizer vaccine 1 on 20Apr2021. 3 hours after my body became sore and remained sore for about two days. On the 3rd day. She began having nerve and muscle pain on the left side of her body. It was now 05May2021. She was now having to get physical therapy. Along with take a prescription Gabapentin. Her intentions are to inform your company, so that you may add it to the list of side effects. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The adverse events resulted in Doctor other healthcare professional office/clinic visit. The events was considered as non serious as per reporter.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Overall leg soreness; basically both of my legs have a lot of extra soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "Overall leg soreness; basically both of my legs have a lot of extra soreness".  Additional information: Well she just had some overall leg soreness since she had the 1st shot, it started couple of days after she had the 1st shot which was not on past Thursday but she guess on 22nd this is when she had the shot and then she had a overall soreness in her leg since the 24th and she don't know if its related or not but it was been persistent enough. When confirmed the shot as Pfizer Covid 19 vaccine, patient stated, Yes it was on 22nd it was just after the 1st shot. When paraphrased the concern, patient stated, Yes, it was primarily, basically both of her legs had a lot of extra soreness that had not been going away and she don't know for sure if its related to the vaccine. When asked if wanted to report or wanted to know why it was happening, consumer stated, Yes, of Couse she don't know if its the common thing and she queried for what could be the cause if any suggestion or this was a common thing.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Caller added with the first dose everything was fine, she had a little fatigue, but all fine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 14Mar2021 09:30 (Lot number: EN6203) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Endometriosis" (ongoing), notes: Verbatim: Endometriosis. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Caller added with the first dose everything was fine, she had a little fatigue, but all fine".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Experienced pain in her armpit area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm, administration date 22Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AXILLARY PAIN (non-serious) with onset 2021, outcome "unknown", described as "Experienced pain in her armpit area".  Additional information: The reporter stated that the patient received the first dose of Pfizer COVID-19 Vaccine on 22APR2021 and reported that the patient experienced pain in her armpit area. The reporter also stated that the Patient's second dose was schedule for 3 weeks after the first dose which is correct but she would like to know if she could take it later like 4 weeks after the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Full blood count, Metabolic function test, Neck pain
Clinical narrative: Excruciating pain on my neck right side; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Apr2021 (Lot number: EN6208, Expiration Date: 30Jun2021) at the age of 51 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Mild asthma" (unspecified if ongoing), notes: Verbatim: Mild asthma; "Rheumatoid arthritis" (unspecified if ongoing), notes: Verbatim: Rheumatoid arthritis; "Hyperlipidaemia" (unspecified if ongoing), notes: Verbatim: Hyperlipidaemia; "Glaucoma" (unspecified if ongoing), notes: Verbatim: Glaucoma in both eyes; "Eczema" (unspecified if ongoing), notes: Verbatim: Eczema; "Vitamin D deficiency" (unspecified if ongoing), notes: Verbatim: Vitamin D deficiency; "Mitral valve prolapse" (unspecified if ongoing), notes: Verbatim: Mitral valve prolapse; "Essential hypertension" (unspecified if ongoing), notes: Verbatim: Essential hypertension; "Oedema" (unspecified if ongoing), notes: Verbatim: Edema; "Blood cholesterol increased" (unspecified if ongoing), notes: Verbatim: High cholesterol. Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN D3 taken for vitamin d deficiency; BENADRYL; LATANOPROST taken for glaucoma; TIMOLOL MALEATE; ALBUTEROL SULFATE; MOBIC; SIMVASTATIN; HYDROCHLOROTHIAZIDE; FLUTICASONE PROPIONATE; OMEPRAZOLE; CALCIUM D3; VITAMIN C [ASCORBIC ACID]. Vaccination history included: Bnt162b2 (Dose 1, Single. Lot Number: EL9266, Expiry date: 31May2021, Anatomical approach site: Arm Left), administration date: 26Mar2021, for COVID-19 immunisation. The following information was reported: NECK PAIN (non-serious) with onset 27Apr2021, outcome "unknown", described as "Excruciating pain on my neck right side". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of neck pain.  Additional information: I have Digestive belly probiotic that I take. It is one tablet a day.There is a explanation point, EBS neutrophils 9.50. I see the result but the doctor hasn't called me back to discuss with me. So, I am looking at the value that came in the test. It gives the range." The patient took Multivitamins. The Patient took Prednisone, methocarbamol , lidocaine the patch and physical therapy   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Crying, Feeling abnormal
Clinical narrative: She was actually crying; Very upset; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CRYING (non-serious), outcome "unknown", described as "She was actually crying"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Very upset".  Additional information: Caller was very upset that no one will talk to her about the side effects she had after her first dose of the Vaccine. She was actually crying. As I was getting her information to transfer she hung up. Will fax on her behalf. She also did say she was supposed to get the vaccine second dose on May 4th but she did not go.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Muscle tightness, Oropharyngeal pain, Sinus disorder
Clinical narrative: feeling a little under the weather with a sore throat and sinus issues.; feeling a little under the weather with a sore throat and sinus issues.; back pains; muscles were real tight; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 82 year-old female patient received bnt162b2 (BNT162B2), administration date 16Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "diabetes" (unspecified if ongoing); "Heart blockages" (unspecified if ongoing). The patient took concomitant medications.  The following information was reported: BACK PAIN (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "back pains"; MUSCLE TIGHTNESS (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "muscles were real tight"; OROPHARYNGEAL PAIN (non-serious), SINUS DISORDER (non-serious), outcome "unknown" and all described as "feeling a little under the weather with a sore throat and sinus issues.". Therapeutic measures were taken as a result of oropharyngeal pain.  Additional information: The female patient who received her 1st dose of the vaccine on 16Apr2021. During the 1st week after her shot, she experienced some back pains, feeling that her muscles were real tight. She cannot distinguish if this was really from the vaccine as she had conditions like diabetes and heart blockages. Because of this, she was on antidiabetic medications, blood-thinners, and anti-acid reflux medications. She mentioned that she felt better by the 2nd week. She was asking if she can take her 2nd dose of the vaccine today because she was feeling a little under the weather with a sore throat and sinus issues. She was gargled and took Tylenol last night and it made her feel a little better. She told that she was on cholesterol medication. She had back pains for about a week after the vaccine. Then it went away and she was just sore. She could not tell if it was the shot or just something she did. Her back was really sore. Her back ached. The back being sore and ached only lasted about 3-4 days.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Lot number: EN6205) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "tiredness".   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Limb discomfort, Muscle tightness
Clinical narrative: big lump underneath her left armpit; feeling muscle tightness; Muscle tightness began yesterday and feels it especially in legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient. A 29-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04May2021 (Lot number: unknown) at the age of 29 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: AXILLARY MASS (non-serious) with onset 06May2021, outcome "not recovered", described as "big lump underneath her left armpit"; MUSCLE TIGHTNESS (non-serious) with onset 06May2021, outcome "not recovered", described as "feeling muscle tightness"; LIMB DISCOMFORT (non-serious) with onset 06May2021, outcome "not recovered", described as "Muscle tightness began yesterday and feels it especially in legs".  Additional Information: Expiry Date of COVID vaccine: Unknown. The patient did not receive other Products. The patient had no history. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Reason for no lot number of COVID vaccine was Other: Caller does not have her COVID vaccine record card at this time. This dose was caller's first dose. Patient took COVID vaccine (Verbatim) because of military action. No additional Vaccines Administered on Same Date of the Pfizer Suspect. Prior Vaccinations (within 4 weeks), no other vaccinations taken within four weeks prior to the first administration date of the suspect vaccine(s). Relevant Tests were none. The thing is, when she raises her arm, you can notice the big lump under her arm. The events did not result into emergency room and Physician office visit. No PQC Present.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: Blisters on his chest; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-healthcare professional) from medical information team. The reporter is the patient. A 85-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Apr2021 10:00 (Lot number: EB8737) at the age of 85 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient concomitant medications were not reported. The following information was reported: BLISTER (non-serious), outcome "recovering", described as "Blisters on his chest". The event "blisters on his chest" was evaluated at the physician office visit.  Additional Information: Patient has received both doses of the Pfizer BioNTech Covid 19 vaccine. His first dose was on 04Apr2021, and he developed blisters on his chest last lasted for a month and did not resolve before receiving the second dose. He received his second shot on 04Apr2021. He now has blisters on different areas- arms, legs, chest and some on his back. His chest was the worst part of it and he has bad scars left from them. Some were berry small and some were quite large, smaller than a penny about half an inch by quarter inch. The small ones were like a ball point pen. He has dry skin and tryies to keep lotion on them. Skin is itchy but not sure if its from the blisters. He has one blister on his arm and one on his leg. He has burst some but he saw his doctor told him not to burst anymore and was prescribed some cream that he still has to pick up from the pharmacy. He saw his family doctor and he could not find any reason why they would be developing. He received his 2nd shot last Saturday on 04May2021, LOT: EW0172, Left arm injection, and is continuing to get blisters all over his body. Caller asked if anyone has had this problem before. The Pharmacist had not seen any one with this reaction. Caller added the blisters are leaving bad looking scars. Caller added after the second vaccine the blisters continued. Caller added he was lucky he is in very good health for his age. Patient not visited Emergency Room.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Palpitations, Respiratory rate decreased
Clinical narrative: Not sleepy but tired and fatigued; Not sleepy but tired and fatigued; Slow breathing, but pulse rate was normal; increase palpitation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administration date 26Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing), notes: She explained she also has anxiety and is pre-diabetic; "Pre-diabetic" (unspecified if ongoing), notes: She explained she also has anxiety and is pre-diabetic; "Chondritis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for Covid-19 immunization. The following information was reported: INSOMNIA (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "Not sleepy but tired and fatigued"; RESPIRATORY RATE DECREASED (non-serious), outcome "unknown", described as "Slow breathing, but pulse rate was normal"; PALPITATIONS (non-serious), outcome "unknown", described as "increase palpitation".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site movement impairment
Clinical narrative: he can't be able to use his left arm and hand; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) by Pfizer from Novartis Pharmaceuticals. The reporter is the patient.  A 75-year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious), outcome "unknown", described as "he can't be able to use his left arm and hand".  Additional Information: Patient states 4-5 days after his COVID-19 vaccine shot he can't be able to use his left arm and hand.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Illness, SARS-CoV-2 antibody test
Clinical narrative: sick; positive Covid test; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A male patient received bnt162b2 (BNT162B2), administration date 27Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick"; COVID-19 (non-serious) with onset 27Apr2021, outcome "unknown", described as "positive Covid test". Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The patient is young and healthy but after getting the vaccination developed Covid. No underlying health issues in perfect health but the shot must've Given him Covid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Dizziness
Clinical narrative: dizziness; She's had chills; stomachache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 09:40 (Batch/Lot number: unknown) at the age of 34 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "gall bladder removed", start date: Nov2020 (not ongoing), notes: Verbatim: last November they removed her gallbladder. Concomitant medication(s) included: VITAMIN D [VITAMIN D NOS]. The following information was reported: DIZZINESS (non-serious) with onset 06May2021, outcome "recovering", described as "dizziness"; CHILLS (non-serious) with onset 06May2021, outcome "recovering", described as "She's had chills"; ABDOMINAL PAIN UPPER (non-serious) with onset 06May2021, outcome "recovering", described as "stomachache".  Additional information: patient received the first dose of Pfizer's covid vaccine on Saturday, 01may2021 (6 days ago). She had chills, a stomachache, and dizziness and they started last night and are still going on but probably getting better. Patient wondering if these symptoms are normal and is it normal to have them this far out and asking if she should get the second dose. It was reported concomitant products she takes vitamin d as a vitamin. She has taken for approximately four weeks. No investigation assessment. Patient does not see lot, ndc, or expiration on her vaccine record card. She received the vaccine around 9:40 am. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. No vaccines administered on same date with the Pfizer vaccine considered as suspect. Patient had not visited emergency room or physician office, did called her physician. No treatment was reported. Any patient had not taken other vaccinations within four weeks prior to the first administration date of the suspect vaccine. No aes following prior vaccinations. Family medical history relevant to aes was reported none that she knows of.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: I am calling to see if it's common that you have increasing fatigue after five days after your shot. I got my shot on Friday, my first one.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "I am calling to see if it's common that you have increasing fatigue after five days after your shot. I got my shot on Friday, my first one.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pain
Clinical narrative: I was very sick; pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (002591). The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: XELJANZ. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I was very sick"; PAIN (non-serious), outcome "unknown", described as "pain". Additional information: Patient called in because she took her Covid vaccination and did not stop medication. Patient stated that medication does not appear to be working as well and she has to take Tylenol to help with the pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Audiogram, Computerised tomogram, Tinnitus
Clinical narrative: Tinnitus-right ear / Constant, buzz pulsating sound; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jan2021 (Lot number: EL1284) at the age of 48 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Osteoarthritis" (unspecified if ongoing), notes: Known allergies: OA. Concomitant medication(s) included: CELEBREX; MYRBETRIQ; VITAMIN D 3; VITAMIN B 12 [CYANOCOBALAMIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EJ1685, Anatomical site: Left arm), for COVID-19 immunisation, reaction(s): "Headache", "tinnitus - right ear, constant, buzzpulsating sound". The following information was reported: TINNITUS (non-serious) with onset 11Jan2021, outcome "not recovered", described as "Tinnitus-right ear / Constant, buzz pulsating sound". The event "tinnitus-right ear / constant, buzz pulsating sound" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of tinnitus.  Additional information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 11Jan2021 after the dose 2, the patient experienced tinnitus-right ear, constant, buzz pulsating sound. Therapeutic measures were taken as a result of events and included treatment with audiotory exam and CT scan.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101441560 Same patient/Vaccine, different event, different vaccine shot
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Influenza like illness, Pain in extremity, Peripheral swelling
Clinical narrative: They both began to have flu like symptoms on 03May.; she noticed that her legs began aching; she experienced swelling on her leg, felt foggy and not feeling well./had swelling in her legs to where her knee high panty hose were cutting off her circulation; she experienced swelling on her leg, felt foggy and not feeling well.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient in her 60's received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 2021, outcome "unknown", described as "she experienced swelling on her leg, felt foggy and not feeling well./had swelling in her legs to where her knee high panty hose were cutting off her circulation"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "she experienced swelling on her leg, felt foggy and not feeling well."; INFLUENZA LIKE ILLNESS (non-serious) with onset 03May2021, outcome "unknown", described as "They both began to have flu like symptoms on 03May."; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "she noticed that her legs began aching".  Additional information: It was reported that in her 60's. She and her husband both received the first covid vaccine dose on April 23rd. The 2nd dose will be on 14May2021. On 03May as per the caller she experienced swelling on her leg, felt foggy and not feeling well. They both began to have flu like symptoms on May 3rd. The caller reports that her symptoms were not as severe reporting that she felt mostly "Foggy" and like she had a light flu, but she was still able to work and go shopping. But she did report that when she was out shopping she noticed that her legs began aching and she realized that her knee high panty hose, which are normally loose and falling down were tight and digging into her legs because her legs were swollen. When she got home she elevated her legs and it eventually went away. She reported that this was concerning as she didn't see it on the list of side effects and their symptoms appeared over 1 week after having the vaccine. Asking was this normal. She also asks if the symptoms can be delayed after the first dose. She had a side effect after the first dose of the vaccine. Should she get the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Polymerase chain reaction, SARS-CoV-2 test
Clinical narrative: arm soreness; slight finger tingles; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Apr2021 13:00 (Lot number: ER8729) at the age of 43 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "eucalyptus" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Ceclor, reaction(s): "Allergies;Ceclor". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "arm soreness"; PARAESTHESIA (non-serious) with onset Apr2021, outcome "unknown", described as "slight finger tingles". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Prior to vaccination, was the patient was not diagnosed with COVID-19, Since the vaccination, patient was tested for COVID-19. patient was not received any other vaccines within 4 weeks prior to the COVID vaccine, patient did not received any other medication within 2 weeks of vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 64 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "vertigo".  Additional information: Reporter wants statistics on reported vertigo for second dose and also stated he has heard reports about vertigo although no information. Nurse Anesthetist calling with a question about an individual that he knows quite well. Caller wants statistics on reported vertigo following second dose. Also asks  if it's positional, Sideling or recumbent. Caller states anecdotally he has heard reports about vertigo although no information. Reporter was asking about cases that have been reported about individuals that experience vertigo after the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia
Clinical narrative: Had an almost metallic-like taste in my mouth on both my first and second shot. Slight burning in the arm only after the second dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 25-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07May2021 11:00 (Batch/Lot number: unknown) at the age of 25 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "attention deficit hyperactivity disorder" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL. The following information was reported: DYSGEUSIA (non-serious) with onset 07May2021 11:30, outcome "recovered", described as "Had an almost metallic-like taste in my mouth on both my first and second shot. Slight burning in the arm only after the second dose.". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: The patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination and since vaccination patient not tested for covid-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Vaccination site pain
Clinical narrative: Had an almost metallic-like taste in my mouth on both my first and second shot. Slight burning in the arm only after the second dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 25-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07May2021 11:00 (Batch/Lot number: unknown) at the age of 25 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "attention deficit hyperactivity disorder" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL. The following information was reported: DYSGEUSIA (non-serious) with onset 07May2021 11:30, outcome "recovered", described as "Had an almost metallic-like taste in my mouth on both my first and second shot. Slight burning in the arm only after the second dose.". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: The patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination and since vaccination patient not tested for covid-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.